Skip to main content
. 2022 Dec 9;101(49):e32250. doi: 10.1097/MD.0000000000032250

Table 2.

Multivariable analysis of prognostic factors.

Variable Hazard ratio (95% CI) P value
Treatment category 2.077 (1.706–2.529) <.001***
ALB ≥ 35(g/L) 2.353 (1.803–3.071) <.001***
PAB ≥ 200(g/L) 1.270 (0.971–1.661) .081
Lymph node metastasis 1.106 (0.856–1.428) .440*
CA19-9 ≥ 1000(U/mL) 1.2239 (0.943–1.587) .129
Tumor diameter > 3 cm 1.335 (1.006–1.772) .046*
Distant metastasis 1.596 (1.160–2.197) .004**
Bismuth-Corlette type 1.277 (1.147–1.422) <.001***
ECOG grade 1.837 (1.436–2.349) <.001***
Vascular encasement 1.328 (0.992–1.778) .057

ALB = albumin, CA19-9 = carbohydrate antigen 19-9, ECOG = Eastern Cooperative Group, PAB = prealbumin.

*

P < .05,

**

P < .01,

***

P < .001.